Where wearable studies actually fail
A great biomarker on one device is still one device.
Empatica's strength is genuine: FDA-cleared medical wearables and a deep catalog of validated digital measures, now extended into neuro. But the model assumes Empatica's hardware. Multi-device protocols, BYOD populations, and studies that need cellular or non-app capture run into the edges of a single-vendor stack, and wear-time recovery still has to come from somewhere. That somewhere is what Delve owns.
Bottom line: If your study fits Empatica's devices and you want a tight device-plus-biomarker stack, Empatica is excellent. If you need validated algorithms across many devices, cellular and non-app capture, and human wear-time recovery, Delve is the better-fitting platform, and it can run Empatica devices too.
Where Empatica and Delve genuinely overlap
At the capability level, both can support a modern wearable-enabled trial. Both typically offer:
- Validated digital biomarkers and objective sensor-derived endpoints
- Regulatory-grade, FDA-aligned digital measures
- Actigraphy, activity, and sleep endpoints
- A focus on defensible, submission-ready data
The differences show up once you ask what happens when a participant stops wearing the device, when a sensor produces unusable data, or when an endpoint depends on validated algorithms across more than one device.
Side-by-side comparison
Empatica vs Delve Health: capability comparison
The table reflects publicly documented positioning and standard delivery models for each platform. Specific configurations vary by contract.
| Capability | Empatica | Delve Health |
|---|---|---|
| Signal quality & endpoint integrity | ||
| Validated digital-endpoint algorithms | Yes — on its own devices | 70+ algorithms across 25+ devices, many vendors |
| Device breadth | Empatica medical wearables | 25+ devices, device-agnostic |
| Cellular / non-app capture | Device-dependent | Yes — BYOD, provisioned, cellular, non-app |
| Signal quality control / completeness | Device-level analytics | Owned QC layer |
| Wear-time recovery (human) | Not a concierge model | Concierge in 120+ languages |
| eCOA / ePRO included | Biomarker focus | Fully configurable eCOA |
| Device logistics & provisioning | Own hardware | End-to-end across devices |
| Per-study completion accountability | Customer-driven | 92–98% documented per study |
| Compliance posture (HIPAA, GDPR, 21 CFR Part 11, GCP, ISO 27001) | Yes | Yes |
Why wearable-heavy studies pick Delve
Four reasons sponsors choose Delve when wearable endpoint integrity, wear-time, or retention is the deliverable — not the customer's problem to solve.
Completion is the deliverable
Delve publishes documented 92–98% per-study eCOA/ePRO completion ranges and up to 63% retention uplift in long-duration cohorts — platform-owned, not the customer's problem to solve.
Validated algorithms across many devices
70+ validated digital-endpoint algorithms across 25+ devices on one harmonized data layer that normalizes units, sampling rates, time bases, QC flags, and algorithm versions.
Signal quality, owned end-to-end
Signal quality control validates completeness, flags drift, and catches sync failures before data is lost — not discovered at database lock.
Humans recover wear-time
Concierge-as-a-Service in 120+ languages recovers participants before wear-time decays — proactive outreach, device troubleshooting, escalation.
Which platform fits your study
Choose the platform that fits your operating model
Choose Empatica if…
- You want a single-vendor, medical-grade device-plus-biomarker stack
- You specifically want Empatica's FDA-cleared devices or neuro capabilities
- You have in-house capacity for wear-time and patient engagement
- You are sourcing a device-and-biomarker, not a full trial-execution platform
Choose Delve Health if…
- Your study spans multiple device classes and you want freedom across vendors
- You need cellular / non-app capture for broad or low-tech populations
- You need signal QC and human wear-time recovery built in
- You want eCOA, logistics, and analytics in one operating model
- You want documented per-study completion (92–98%)
Frequently asked questions
Questions sponsors ask when comparing Empatica and Delve Health
Is Delve Health an Empatica alternative?
They overlap but differ in model. Empatica is a vertically integrated medical wearable and digital-biomarker vendor on its own hardware. Delve is a device-agnostic execution platform that runs validated algorithms across many device classes and adds signal quality control, wear-time recovery, eCOA, and concierge. Single-vendor studies may prefer Empatica; multi-device, execution-critical studies typically prefer Delve.
What is the difference between a single-vendor stack and a device-agnostic platform?
Empatica ties the endpoint to its own devices and biomarkers. Delve runs 70+ validated algorithms across 25+ devices on one harmonized data layer, so you are not locked to one hardware vendor and can fit the device to the protocol and population rather than the reverse.
Does Empatica include human wear-time recovery or concierge support?
Empatica focuses on devices and digital biomarkers, not a concierge support model. Delve includes Concierge-as-a-Service in 120+ languages that proactively recovers wear-time before data goes missing.
Can Delve use Empatica devices in a study?
Delve integrates many device classes and is device-agnostic by design. The deciding question for sponsors is usually whether they want a single-vendor device-and-biomarker stack or a platform that turns any supported device into a usable endpoint with QC, wear-time recovery, and eCOA around it.
Which is better for digital biomarker endpoints?
Both deliver validated digital biomarkers. Empatica goes deep on its own hardware; Delve runs validated algorithms across many devices and pairs them with the signal QC and wear-time execution that protect the endpoint across a full study population.
Evaluating Delve against Empatica?
Ask each vendor one question: what happens to your endpoint when a participant stops wearing the device? The answer tells you more than any device list.
Book a Platform Walkthrough